Anti-inflammatory
Etoricoxib
A selective COX-2 inhibitor NSAID used in oral formulations for osteoarthritis, rheumatoid arthritis, and acute pain and gout flares.
Etoricoxib is a next-generation selective COX-2 inhibitor API manufactured by NovaAcura Biotech under GMP-compliant conditions. Full batch documentation and regulatory support are available for global formulation partners.
Applications & Uses
A selective COX-2 inhibitor NSAID used in oral formulations for osteoarthritis, rheumatoid arthritis, and acute pain and gout flares.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch